194 related articles for article (PubMed ID: 31267666)
1. Clinical outcomes and economic impact of the 2017 ACC/AHA guidelines on hypertension in China.
Wang Z; Hao G; Wang X; Chen Z; Zhang L; Zhang Z; Hu H; Weintraub WS; Gao R;
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1212-1220. PubMed ID: 31267666
[TBL] [Abstract][Full Text] [Related]
2. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.
Khera R; Lu Y; Lu J; Saxena A; Nasir K; Jiang L; Krumholz HM
BMJ; 2018 Jul; 362():k2357. PubMed ID: 29997129
[TBL] [Abstract][Full Text] [Related]
3. Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
Bress AP; Colantonio LD; Cooper RS; Kramer H; Booth JN; Odden MC; Bibbins-Domingo K; Shimbo D; Whelton PK; Levitan EB; Howard G; Bellows BK; Kleindorfer D; Safford MM; Muntner P; Moran AE
Circulation; 2019 Jan; 139(1):24-36. PubMed ID: 30586736
[TBL] [Abstract][Full Text] [Related]
4. Lifetime Risks for Hypertension by Contemporary Guidelines in African American and White Men and Women.
Chen V; Ning H; Allen N; Kershaw K; Khan S; Lloyd-Jones DM; Wilkins JT
JAMA Cardiol; 2019 May; 4(5):455-459. PubMed ID: 30916719
[TBL] [Abstract][Full Text] [Related]
5. Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them.
Jiao Y; Sun Z; Xie Y; Zheng J; Li Z; Guo X; Dai Y; Zheng L; Sun Y
BMC Cardiovasc Disord; 2020 May; 20(1):237. PubMed ID: 32429909
[TBL] [Abstract][Full Text] [Related]
6. Potential Impact of the 2017 High Blood Pressure Guideline Beyond the United States: A Case Study of the People's Republic of China.
Barszczyk A; Yang D; Wei J; Huang W; Feng ZP; Lee K; Luo H
Am J Hypertens; 2020 Sep; 33(9):846-851. PubMed ID: 32521545
[TBL] [Abstract][Full Text] [Related]
7. Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.
Gijón-Conde T; Sánchez-Martínez M; Graciani A; Cruz JJ; López-García E; Ortolá R; Rodríguez-Artalejo F; Banegas JR
J Hypertens; 2019 Jul; 37(7):1393-1400. PubMed ID: 31145710
[TBL] [Abstract][Full Text] [Related]
8. Chinese Physicians' Perspectives on the 2017 American College of Cardiology/American Heart Association Hypertension Guideline: A Mobile App-Based Survey.
Ni Z; He J; Wang JG; Cao J; Yang Q; Wu B; Shaw RJ
High Blood Press Cardiovasc Prev; 2019 Jun; 26(3):247-257. PubMed ID: 31201617
[TBL] [Abstract][Full Text] [Related]
9. Isolated diastolic hypertension as defined by the 2017 American College of Cardiology/American Heart Association blood pressure guideline and incident cardiovascular events in Chinese.
Wu S; Ji C; Shi J; Chen S; Huang Z; Jonas JB
J Hypertens; 2021 Mar; 39(3):519-525. PubMed ID: 33031180
[TBL] [Abstract][Full Text] [Related]
10. Potential epidemiological impact of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on the Chinese population: a cross-sectional study in rural areas of Liaoning Province.
Dong Y; Sun Z; Li Z; Guo X; Sun G; Xie Y; Zheng J; Dai Y; Wang Y; Guo R; Zheng L; Sun Y
BMJ Open; 2020 Sep; 10(9):e035900. PubMed ID: 32963064
[TBL] [Abstract][Full Text] [Related]
11. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of hypertension therapy according to 2014 guidelines.
Moran AE; Odden MC; Thanataveerat A; Tzong KY; Rasmussen PW; Guzman D; Williams L; Bibbins-Domingo K; Coxson PG; Goldman L
N Engl J Med; 2015 Jan; 372(5):447-55. PubMed ID: 25629742
[TBL] [Abstract][Full Text] [Related]
13. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.
Moise N; Huang C; Rodgers A; Kohli-Lynch CN; Tzong KY; Coxson PG; Bibbins-Domingo K; Goldman L; Moran AE
Hypertension; 2016 Jul; 68(1):88-96. PubMed ID: 27181996
[TBL] [Abstract][Full Text] [Related]
14. Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline.
Dorans KS; Mills KT; Liu Y; He J
J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858369
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes.
Muntner P; Whelton PK; Woodward M; Carey RM
Diabetes Care; 2018 Nov; 41(11):2322-2329. PubMed ID: 30150235
[TBL] [Abstract][Full Text] [Related]
16. Population impact of the 2017 ACC/AHA guidelines compared with the 2013 ESH/ESC guidelines for hypertension management.
Vaucher J; Marques-Vidal P; Waeber G; Vollenweider P
Eur J Prev Cardiol; 2018 Jul; 25(10):1111-1113. PubMed ID: 29637794
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Drug Treatment for Chinese Patients With Stage I Hypertension According to the 2017 Hypertension Clinical Practice Guidelines.
Zhou YF; Liu N; Wang P; Jeong Yang J; Song XY; Pan XF; Zhang X; He M; Li H; Gao YT; Xiang YB; Wu T; Yu D; Pan A
Hypertension; 2020 Sep; 76(3):750-758. PubMed ID: 32713271
[TBL] [Abstract][Full Text] [Related]
18. Eligibility to treatment and economic effect of the implementation of the new U.S. or European Society of Hypertension/European Society of Cardiology hypertension guidelines.
Marques-Vidal P; Waeber G; Waeber B; Vollenweider P
J Hypertens; 2015 Apr; 33(4):868-73. PubMed ID: 25915892
[TBL] [Abstract][Full Text] [Related]
19. Baseline Blood Pressure, the 2017 ACC/AHA High Blood Pressure Guidelines, and Long-Term Cardiovascular Risk in SPRINT.
Vaduganathan M; Pareek M; Qamar A; Pandey A; Olsen MH; Bhatt DL
Am J Med; 2018 Aug; 131(8):956-960. PubMed ID: 29421687
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Populations Excluded From Clinical Trials Supporting Intensive Blood Pressure Control Guidelines.
Anderson TS; Odden MC; Penko J; Kazi DS; Bellows BK; Bibbins-Domingo K
J Am Heart Assoc; 2021 Apr; 10(7):e019707. PubMed ID: 33754796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
